Alector (ALEC) Cash from Investing Activities (2018 - 2026)

Alector (ALEC) reported Cash from Investing Activities of $60.9 million for Q1 2026, down 7.28% year-over-year from $65.7 million in Q1 2025, and up 138.1% quarter-over-quarter from $25.6 million in Q4 2025.

Alector (ALEC) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Cash from Investing Activities data on file, last reported at $60.9 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $60.9 million, down 7.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $191.8 million (up 3.89% YoY), and the FY2025 annual result was $196.6 million, up 83.51% from the prior year.
  • Cash from Investing Activities improved to $60.9 million in Q1 2026 per ALEC's latest filing, from $25.6 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $88.7 million in Q1 2023 and troughed at -$225.8 million in Q2 2022.
  • A 5-year average of $18.1 million and a median of $37.1 million in 2024 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities plunged 499.04% in 2022, then jumped 832.7% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at $18.4 million in 2022, then decreased by 1.69% to $18.1 million in 2023, then jumped by 129.11% to $41.4 million in 2024, then slumped by 38.17% to $25.6 million in 2025, then jumped by 138.1% to $60.9 million in 2026.
  • Business Quant data shows ALEC's Cash from Investing Activities at $60.9 million in Q1 2026, $25.6 million in Q4 2025, and $49.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Alector 193.53 Mn -12.98 Mn - 60.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.95 Mn
Mar 31, 2026 60.95 Mn
Dec 31, 2025 25.60 Mn
Dec 31, 2025 25.60 Mn
Sep 30, 2025 49.54 Mn
Sep 30, 2025 49.54 Mn
Jun 30, 2025 55.72 Mn
Jun 30, 2025 55.72 Mn
Mar 31, 2025 65.74 Mn
Mar 31, 2025 65.74 Mn
Dec 31, 2024 41.40 Mn
Dec 31, 2024 41.40 Mn
Sep 30, 2024 40.35 Mn
Sep 30, 2024 40.35 Mn
Jun 30, 2024 37.15 Mn
Jun 30, 2024 37.15 Mn
Mar 31, 2024 -11.77 Mn
Mar 31, 2024 -11.77 Mn
Dec 31, 2023 18.07 Mn
Dec 31, 2023 18.07 Mn